A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 VaccinePfizer-BioNTech BNT162b2 mRNA COVID-19 백신 1차 접종 7일 후 광범위한 심부 정맥 혈전증 및 폐 혈전색전증을 앓고 있는 59세 여성Case Reports Published on 2021-06-122022-09-11 Journal: The American journal of case reports [Category] SARS, 변종, [키워드] Anticoagulant approved association BNT162b2 BNT162b2 mRNA Case report COVID-19 COVID-19 pandemic COVID-19 vaccine Day deep Deep vein Deep vein thrombosis Department diagnosed discharged home DVT ELISA test Emergency emergency department Extensive first dose global healthcare heparin heparin-induced thrombocytopenia Hospitalized mRNA of BNT162b2 optical optical density Pain Pfizer-BioNTech positive present pulmonary Pulmonary embolism receiving rivaroxaban Support thrombocytopenia Thromboembolism thrombosis Thrombotic thrombocytopenia vaccination Vaccine variant Vein woman [DOI] 10.12659/AJCR.932946 PMC 바로가기 [Article Type] Case Reports
COVID-19 Pandemic and Equal Access to VaccinesCommentary Published on 2021-05-212022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] access Adequate Administered adopted Affect affected appear applied build Community COVAX COVID-19 COVID-19 pandemic criteria criterion Culture distribution domain Equal equity European evidenced global healthcare higher risk implementation Infection Intervention pandemic parameter Population priority Protective public health receive supported union vaccination Vaccine Vaccines WHO World Health Organization [DOI] 10.3390/vaccines9060538 PMC 바로가기 [Article Type] Commentary
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?레스베라트롤 흡입 제형이 COVID-19에 대한 잠재적인 보조 치료제로 간주될 수 있습니까?Review Published on 2021-05-192022-09-11 Journal: Frontiers in Immunology [Category] SARS, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adjunct administration airways Anti-inflammatory Antiviral antiviral activities antiviral activity antiviral drug Asymptomatic Bioavailability Can caused Cell culture Characteristics characterized Clinical practice Compound Concentration coronavirus COVID-19 COVID-19 severity cytokine Cytokine storm disease downregulate effective epithelial epithelial cell evaluated excessive inflammatory response experimental models Formulation global healthcare IMPROVE Infection Inhaled inhaled formulations inhibit SARS-CoV-2 involved leads mechanism Mild molecule monoclonal antibodies oral administration outcomes pandemic Patient pharmacokinetic Pneumonia polyphenol Potential Replication respiratory Respiratory failure respiratory tract illness resveratrol Safe SARS-CoV-2 SARS-CoV-2 replication severe viral pneumonia shown Treatment upper respiratory tract Viral Viral pneumonia viral replication [DOI] 10.3389/fimmu.2021.670955 PMC 바로가기 [Article Type] Review
A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19Family/General Practice Published on 2021-05-162022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Administered adverse effect adverse effects Against approval authority Axillary Lymphadenopathy Breast cancer caused Cervical cervical lymphadenopathy change coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death differential diagnosis Effect epidemiologists etiology female first dose General population Germany global healthcare growth Inc. increase in information lack lymph Lymphadenopathy Medicine Moderna morbidity national regulatory authority New York pandemic Patient Pfizer Pfizer-BioNTech Portugal Prevent product radiologist receiving reported Safe Side effect the patient Ultrasound vaccination vaccination against COVID-19 Vaccine Vaccines [DOI] 10.7759/cureus.15050 PMC 바로가기 [Article Type] Family/General Practice
Treatment With Remdesivir in Two Pregnant Patients With COVID-19 PneumoniaObstetrics/Gynecology Published on 2021-05-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] coronavirus coronavirus disease COVID-19 fetal global healthcare intensive care intensive care treatment outcome pandemic Pneumonia Pregnancy Radiological Diagnosis Remdesivir required severe coronavirus disease Severe COVID-19 Infection severe disease Side effects treated Treatment women [DOI] 10.7759/cureus.14986 PMC 바로가기 [Article Type] Obstetrics/Gynecology
An integrated autoencoder-based hybrid CNN-LSTM model for COVID-19 severity prediction from lung ultrasound폐 초음파에서 COVID-19 심각도 예측을 위한 통합 자동 인코더 기반 하이브리드 CNN-LSTM 모델Article Published on 2021-05-012022-09-11 Journal: Computers in biology and medicine [Category] SARS, 치료기술, [키워드] alternative method alternative methods Analysis average build CNN Convolutional neural network COVID-19 COVID-19 pandemic COVID-19 severity creating deep deep learning Diagnosis disease severity effective Efficacy feature flexible fused global healthcare integration Long lung Lung ultrasound Neural Neural network performed predict Safe Severity Score Short-Term Memory the patient threat Ultrasound [DOI] 10.1016/j.compbiomed.2021.104296 PMC 바로가기 [Article Type] Article
Global Healthcare Resource Efficiency in the Management of COVID-19 Death and Infection Prevalence RatesPublic Health Published on 2021-04-292022-10-31 Journal: Frontiers in Public Health [Category] Coronavirus, MERS, SARS, [키워드] absence Alter Analysis approach assumption average Bank Contact tracing country COVID-19 COVID-19 pandemic Data envelopment analysis death death rate death rates Efficiency global healthcare global infection Healthcare system healthcare systems efficiency infection rate infection rates Intervention Isolation Mask pandemic Pandemics provide raising Rate rate of infection recoveries resource social distancing technical efficiency Vaccine Worldometer [DOI] 10.3389/fpubh.2021.638481 PMC 바로가기 [Article Type] Public Health
An Implementation Research Approach to Re-orient Health Supply Chains Toward an Equity Agenda in the COVID-19 EraViewpoint Published on 2021-04-232022-10-27 Journal: Annals of Global Health [Category] Coronavirus, MERS, SARS, [키워드] analyzed applicability approach Care chain COVID-19 Critical distribution Efficiency equity facilitator finding global healthcare Health help identify implementation Intervention medications methodology National outcomes pandemic Population positive Regulation Research supply Vaccine Vaccines [DOI] 10.5334/aogh.3209 PMC 바로가기 [Article Type] Viewpoint
The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19Medicine Published on 2021-04-232022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] ACE2 Administered administration Alter Anti-inflammatory anti-inflammatory drug anti-SARS-CoV-2 Anti-viral Anticoagulant Antithrombotic applicability approach ARDS binding Blood complement Complication Corticosteroid COVID-19 COVID-19 disease severity COVID-19 severity Cytokine storm death case death rate Deleterious derivatives detrimental Dexamethasone diabetics disease downregulation drug early stage ENhance Evidence exacerbated feasible fibrinolytic global healthcare glucocorticoid glucocorticoid dexamethasone groups heparin highlight hyperglycemia hypertensive patients IL-6 immune responses impairing Inflammation initial Invasive mechanical ventilation LTB medical condition modulate Mounting Occurrence Patient presenting Prominent Protein reduce required respiratory risk SARS-CoV-2 secretion severe COVID-19 patients severe patients significantly sodium spike standard treatment therapy Treatment upregulated viral clearance viral infection viral infectivity [DOI] 10.3389/fmed.2021.615333 PMC 바로가기 [Article Type] Medicine
An Early Warning Tool for Predicting Mortality Risk of COVID-19 Patients Using Machine LearningArticle Published on 2021-04-212022-10-31 Journal: Cognitive Computation [Category] COVID-19, [키워드] age AUC Biomarker Blood calculated China Clinical characteristics conducted COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients COVID-19 positive patient cutoff value dataset death demographic disease Early warning tool extreme global healthcare group help high mortality High-sensitivity C-reactive protein hospital identify IMPROVE investigated less lymphocyte machine learning management Mortality mortality risk neutrophil outcome Patient patients predict Predicting mortality risk predictor Probability prognostic model reduce mortality resource Retrospective study risk of COVID-19 severity Stratification the disease Tongji Hospital validation cohort [DOI] 10.1007/s12559-020-09812-7 PMC 바로가기 [Article Type] Article